Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Quanex Building Products CORP Director's Dealing 2021

Feb 10, 2021

14840_dirs_2021-02-10_10bdb392-46f9-4bb5-a5a8-74a767eb8149.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Quanex Building Products CORP (NX)
CIK: 0001423221
Period of Report: 2021-02-08

Reporting Person: GRIFFITHS WILLIAM C (Director, Executive Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-08 Common Stock M 500 $16.72 Acquired 234136 Direct
2021-02-08 Common Stock M 37076 $17.63 Acquired 271212 Direct
2021-02-08 Common Stock S 37576 $24.9721 Disposed 233636 Direct
2021-02-09 Common Stock M 18724 $17.63 Acquired 252360 Direct
2021-02-09 Common Stock M 10026 $20.28 Acquired 262386 Direct
2021-02-09 Common Stock S 28750 $24.7128 Disposed 233636 Direct
2021-02-10 Common Stock M 15792 $20.28 Acquired 249428 Direct
2021-02-10 Common Stock S 15792 $24.4571 Disposed 233636 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-08 Stock Options (Right to Buy) $16.72 M 500 Disposed 2023-07-09 Common Stock (500) Direct
2021-02-08 Stock Options (Right to Buy) $17.63 M 37076 Disposed 2023-12-05 Common Stock (37076) Direct
2021-02-09 Stock Options (Right to Buy) $17.63 M 18724 Disposed 2023-12-05 Common Stock (18724) Direct
2021-02-09 Stock Options (Right to Buy) $20.28 M 10026 Disposed 2024-12-03 Common Stock (10026) Direct
2021-02-10 Stock Options (Right to Buy) $20.28 M 15792 Disposed 2024-12-03 Common Stock (15792) Direct

Footnotes

F1: The stock options were exercised pursuant to a Rule 10b5-1 preset diversification program previously adopted by the reporting person.

F2: The price reported in Column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $24.82 to $25.08, inclusive. The reporting person undertakes to provide to Quanex Building Products Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3: The price reported in Column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $24.32 to $24.91, inclusive. The reporting person undertakes to provide to Quanex Building Products Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F4: The price reported in Column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $24.27 to $24.89, inclusive. The reporting person undertakes to provide to Quanex Building Products Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F5: The options become exercisable in 1/3 increments annually beginning one year from the grant date.